Literature DB >> 26865837

Effects of Demographics and OTC Analgesics on Ovarian Cancer Symptoms.

Kimberly A Lowe1, M Robyn Andersen2, Jeannette C Kane3, Marissa D Robertson3, Barbara A Goff3.   

Abstract

Several independent studies have shown that ovarian cancer is not a silent disease and that many women have symptoms before diagnosis. These symptoms include abdominal/pelvic pain, feeling full quickly, and bloating. However, little information is known about what personal characteristics, medical conditions, or habits influence these symptoms or how they are reported. This report evaluates and describes factors that may be associated with how a patient reports these symptoms. We show that a small number of characteristics, include race, number of gynecologic conditions, and reason for clinic visit, may influence what symptoms are reported and the specific pattern of reporting.

Entities:  

Keywords:  Symptoms Index; ovarian cancer; over-the-counter pain medications

Year:  2013        PMID: 26865837      PMCID: PMC4745902          DOI: 10.1016/j.nurpra.2012.06.008

Source DB:  PubMed          Journal:  J Nurse Pract        ISSN: 1555-4155            Impact factor:   0.767


  13 in total

1.  Standardizing diagnostic markers to evaluate and compare their performance.

Authors:  Margaret Sullivan Pepe; Gary Longton
Journal:  Epidemiology       Date:  2005-09       Impact factor: 4.822

2.  Changes in cancer worry associated with participation in ovarian cancer screening.

Authors:  M Robyn Andersen; Charles W Drescher; Yingye Zheng; Deborah J Bowen; Susan Wilson; Alicia Young; Martin McIntosh; Barry S Mahony; Kimberly A Lowe; Nicole Urban
Journal:  Psychooncology       Date:  2007-09       Impact factor: 3.894

3.  Psychological and behavioral impact of receipt of a "normal" ovarian cancer screening test.

Authors:  Joseph E Gaugler; Edward Pavlik; John M Salsman; Michael A Andrykowski
Journal:  Prev Med       Date:  2006-03-24       Impact factor: 4.018

4.  Predictive value of symptoms for early detection of ovarian cancer.

Authors:  Mary Anne Rossing; Kristine G Wicklund; Kara L Cushing-Haugen; Noel S Weiss
Journal:  J Natl Cancer Inst       Date:  2010-01-28       Impact factor: 13.506

Review 5.  Ovarian cancer: epidemiology, biology, and prognostic factors.

Authors:  C H Holschneider; J S Berek
Journal:  Semin Surg Oncol       Date:  2000 Jul-Aug

6.  Ethnic differences in survival among women with ovarian carcinoma.

Authors:  Jill S Barnholtz-Sloan; Michael A Tainsky; Judith Abrams; Richard K Severson; Faisal Qureshi; Suzanne M Jacques; Nancy Levin; Ann G Schwartz
Journal:  Cancer       Date:  2002-03-15       Impact factor: 6.860

7.  Development of an ovarian cancer symptom index: possibilities for earlier detection.

Authors:  Barbara A Goff; Lynn S Mandel; Charles W Drescher; Nicole Urban; Shirley Gough; Kristi M Schurman; Joshua Patras; Barry S Mahony; M Robyn Andersen
Journal:  Cancer       Date:  2007-01-15       Impact factor: 6.860

8.  Ovarian cancer risk factors in African-American and white women.

Authors:  Patricia G Moorman; Rachel T Palmieri; Lucy Akushevich; Andrew Berchuck; Joellen M Schildkraut
Journal:  Am J Epidemiol       Date:  2009-07-15       Impact factor: 4.897

9.  Combining a symptoms index with CA 125 to improve detection of ovarian cancer.

Authors:  M Robyn Andersen; Barbara A Goff; Kimberly A Lowe; Nathalie Scholler; Lindsay Bergan; Charles W Dresher; Pamela Paley; Nicole Urban
Journal:  Cancer       Date:  2008-08-01       Impact factor: 6.860

10.  Women at risk of ovarian cancer.

Authors:  J Wardle
Journal:  J Natl Cancer Inst Monogr       Date:  1995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.